1. Home
  2. NNNN vs MTX Comparison

NNNN vs MTX Comparison

Compare NNNN & MTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • MTX
  • Stock Information
  • Founded
  • NNNN 2021
  • MTX 1968
  • Country
  • NNNN Germany
  • MTX United States
  • Employees
  • NNNN N/A
  • MTX N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • MTX Major Chemicals
  • Sector
  • NNNN Health Care
  • MTX Industrials
  • Exchange
  • NNNN Nasdaq
  • MTX Nasdaq
  • Market Cap
  • NNNN 2.2B
  • MTX 1.8B
  • IPO Year
  • NNNN 2025
  • MTX 1992
  • Fundamental
  • Price
  • NNNN $27.36
  • MTX $57.48
  • Analyst Decision
  • NNNN
  • MTX Strong Buy
  • Analyst Count
  • NNNN 0
  • MTX 2
  • Target Price
  • NNNN N/A
  • MTX $82.00
  • AVG Volume (30 Days)
  • NNNN 39.8K
  • MTX 183.7K
  • Earning Date
  • NNNN 04-28-2026
  • MTX 10-23-2025
  • Dividend Yield
  • NNNN N/A
  • MTX 0.77%
  • EPS Growth
  • NNNN N/A
  • MTX N/A
  • EPS
  • NNNN 0.06
  • MTX N/A
  • Revenue
  • NNNN $8,185,146.00
  • MTX $2,071,200,000.00
  • Revenue This Year
  • NNNN N/A
  • MTX N/A
  • Revenue Next Year
  • NNNN N/A
  • MTX $3.78
  • P/E Ratio
  • NNNN $503.50
  • MTX N/A
  • Revenue Growth
  • NNNN 21.95
  • MTX N/A
  • 52 Week Low
  • NNNN $5.18
  • MTX $49.54
  • 52 Week High
  • NNNN $55.65
  • MTX $86.49
  • Technical
  • Relative Strength Index (RSI)
  • NNNN 54.26
  • MTX 47.46
  • Support Level
  • NNNN $12.93
  • MTX $56.20
  • Resistance Level
  • NNNN $25.20
  • MTX $58.34
  • Average True Range (ATR)
  • NNNN 4.99
  • MTX 1.47
  • MACD
  • NNNN 1.61
  • MTX 0.28
  • Stochastic Oscillator
  • NNNN 73.40
  • MTX 79.41

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About MTX Minerals Technologies Inc.

Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of its customers' finished products. The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve its customers' manufacturing processes and projects. The majority of revenue comes from the United States.

Share on Social Networks: